Divalproex sodium regulates ataxin-3 translocation likely by an importin α1-dependent pathway.


Journal

Neuroreport
ISSN: 1473-558X
Titre abrégé: Neuroreport
Pays: England
ID NLM: 9100935

Informations de publication

Date de publication:
07 08 2019
Historique:
pubmed: 21 5 2019
medline: 31 3 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

Nuclear localization of ataxin-3 plays a fundamental role in seeding aggregation and the pathology of spinocerebellar ataxia type 3 (SCA3). However, very few compounds that are able to modulate the nuclear transport of ataxin-3 have been identified. In our previous study, we found that divalproex sodium (DVS) reduced heat shock-induced nuclear localization of ataxin-3. However, the mechanism of DVS in the translocation of ataxin-3 still remains unknown. There is accumulating evidence that importins are regulated by acetylation, and histone deacetylase inhibitors can interrupt this process. With this in mind, we used cells coexpressing ataxin-3 and importin α1 (encoded by KNPA2) to probe whether ataxin-3 is the shuttling cargo of importins and whether DVS plays a role in the nuclear transport of ataxin-3 through the transport protein pathway. Here, we reported that importin α1 enhanced nuclear amount of ataxin-3 and increased the aggregate formation and that DVS restored it to the normal level. Importantly, ataxin-3 is shown to directly bind to importin α1. Moreover, DVS modulated the function of importin α1 likely by altering its localization. We believe that this study provides a proof of principle for addressing the mechanism of DVS and furthers our understanding of the role of importins in the nuclear accumulation of ataxin-3 in SCA3.

Identifiants

pubmed: 31107713
doi: 10.1097/WNR.0000000000001246
doi:

Substances chimiques

alpha Karyopherins 0
karyopherin alpha 2 0
Valproic Acid 614OI1Z5WI
Ataxin-3 EC 3.4.19.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

760-764

Auteurs

Zijian Wang (Z)

Genetic Engineering Laboratory, College of Biological and Environmental Engineering, Xi'an University, Xi'an, China.
Institute of Medical Genetics and Applied Genomics, University of Tuebingen.
Center for Rare Diseases (ZSE), University Hospital Tuebingen, Tuebingen, Germany.

Fengqin He (F)

Genetic Engineering Laboratory, College of Biological and Environmental Engineering, Xi'an University, Xi'an, China.

Mahkameh Abeditashi (M)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen.
Center for Rare Diseases (ZSE), University Hospital Tuebingen, Tuebingen, Germany.

Thorsten Schmidt (T)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen.
Center for Rare Diseases (ZSE), University Hospital Tuebingen, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH